Feb 13(Thu) HBS Club of Japan, “The Future of Japan’s Healthcare” with Milano Furuta, new CFO of Takeda
Leaders in healthcare will tackle the pressing challenge together
with the audience to discover new solutions.
Members and friends of the Harvard Club of Japan are kindly invited to the following event by HBS Club of Japan and Innovation for Healthcare, Inc.
Registration: HBS X Innovation for Healthcare/医療産業成長戦略セミナー | Peatix
Date: Thursday, February 13, 2025, 18:30-20:50
Venue: Tokyo International Forum Glass Building (Please find the details via the link above.)
(This event is held in Japanese)
As one of the world’s leading nations in drug discovery, Japan has made significant contributions to healthcare. How can Japan overcome the pressing challenge of its "declining capacity for innovation"?
HBS Club of Japan regularly hosts events regarding healthcare. This time, in collaboration with Innovation for Healthcare, Inc.(CEO: Yuriko Fujii, HBS AMP), we have the honor to welcome Mr. Milano Furuta, CFO of Takeda Pharmaceutical Co. Ltd. As a young leader managing operations across 80 countries/regions with 50,000 employees, Mr. Furuta will discuss about "Driving Corporate Transformation and Innovation: Challenges in Management."
The moderator will be Mr. Osamu Nagayama, Honorary Chairman of Chugai Pharmaceutical, also Chairman of "Growth Strategy for Healthcare", a monthly innovation forum for CEO and C-level executives in healthcare, which Innovation for Healthcare has been organizing for 31 years under the leadership of top bureaucrats and powerful leaders in healthcare. Additionally, the discussion will feature Mr. Masato Iwasaki, former Representative Director of Takeda(HBS PLD), and Dr. Shinsuke Muto, Chairman of Integrity Healthcare, who are senior advisers of Growth Strategy for Healthcare.
Speaker
Mr. Milano Furuta（CFO of Takeda Pharmaceutical Co. Ltd.）
Mr, Furuta joined Takeda in 2010, and has worked on various projects in corporate strategy, corporate development, and post-merger integration in Japan and Switzerland. He managed the Diabetes Business Unit in Mexico, served as general manager in Sweden, leading the launch of new products, corporate strategy officer and chief of staff in Japan for two years, and president of Japan Pharma Business Unit of Takeda for three years before being appointed to his current role.
Prior to joining Takeda, Mr. Furuta worked as an equity research analyst at an investment management firm in the United States. He began his career in banking and private equity investment in Japan.
Mr. Furuta holds an MBA from The Wharton School of the University of Pennsylvania, and a bachelor’s degree in international affairs from Hitotsubashi University in Japan.
Moderator
Mr. Osamu Nagayama (Chairman of Growth Strategy for Healthcare)
Honorary Chairman of Chugai Pharmaceutical Co., Ltd., Representative Director and Chairman of the Board of the Japan Bioindustry Association, Chairman of the Bio-Strategy Council for Strengthening Innovation Policy of the Cabinet Office, Former Chairman of the Japan Pharmaceutical Manufacturers Association, Former Outside Director and Chairman of the Board of Sony Corporation.
Other leaders in Japanese healthcare
Mr. Masato Iwasaki (Senior advisor of Growth Strategy for Healthcare)
PhD, HBS PLD, Former Representative Director of Takeda Pharmaceutical Co., Ltd., Outside Director of Olympus Corporation, Senior Executive Fellow of IGPI Group, Vice Chairman of the Japan Pharmaceutical Manufacturers Association, Executive Member of the Keizai Doyukai (Japan Association of Corporate Executives), and Chairman of the Osaka Pharmaceutical Industry Club.
Dr. Shinsuke Muto (Senior advisor of Growth Strategy for Healthcare)
MD both in Japan & US, MPH, PhD, MSc, MBA, Executive MBA, Chairman of the Board of Directors of Integrity Healthcare, Tetsuyu-kai Medical Corporation, and and CHCP. Former cardiologist at University of Tokyo Hospital, physician for the royal family/the Imperial Household Agency, management consultant at McKinsey, winner of the 2015 Innovator of the Year Award, graduate of University of Tokyo Faculty of Medicine, MBA from Waseda University, Executive MBA from INSEAD.